Leslie Tari, Chief Scientific Officer at Cidara Therapeutics, Inc. (CDTX), sold 1,252 shares at $1.25 ($2K) on 2022-01-05, disclosed to the SEC on 2022-01-07.
Open-market sale of $2k CDTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CDTX | SELL | 2024-03-12 | $14K | — | Filing → |
| CDTX | SELL | 2023-09-13 | $18K | — | Filing → |
| CDTX | BUY | 2023-08-14 | $10K | — | Filing → |